Shanxi Zhendong Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanxi Zhendong Pharmaceutical Co Ltd with three other
companies in this sector in China:
ChangChun High New Technology Industries
sales of 2.37 billion Chinese Renmimbi [US$347.23 million]
of which 79%
Zhejiang Jianfeng Group Company Limited
(2.26 billion Chinese Renmimbi [US$330.13 million]
of which 45%
was Pharmaceutical), and
Shenzhen Hepalink Pharmaceutical Company Limited
(2.29 billion Chinese Renmimbi [US$334.79 million]
of which 100%
was Pharmaceutical Manufacturing).
During the year ended December of 2015, sales at
Shanxi Zhendong Pharmaceutical Co Ltd were 2.26 billion Chinese Renmimbi (US$330.74 million).
increase of 17.9%
versus 2014, when the company's sales were 1.92 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shanxi Zhendong Pharmaceutical Co Ltd
(and since 2010, sales have increased a total of 143%).
Sales of Medicinal Curb Planting saw an increase
35.1% in 2015, from
77.54 million Chinese Renmimbi to 104.73 million Chinese Renmimbi.
Not all segments of Shanxi Zhendong Pharmaceutical Co Ltd experienced an increase in sales in 2015:
sales of Other fell 13.2% to 14.62 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).